28
Participants
Start Date
April 30, 2006
Study Completion Date
October 31, 2007
sulindac
pharmacological study
Mayo Clinic Cancer Center, Rochester
Lead Sponsor
National Cancer Institute (NCI)
NIH
Mayo Clinic
OTHER